Illumina, Inc.
Illumina, Inc. (ILMN) provides sequencing and array-based solutions for genetic analysis, with a primary political signal being $139.5M in federal contracts across 11 agencies and direct executive branch exposure via a Trump-held stock position.
BusinessWhat ILMN does
Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its revenue is derived from the sale of sequencing instruments, consumables, and associated services, primarily to academic, government, pharmaceutical, and biotechnology customers. The company's business model is heavily reliant on research funding and public health initiatives.
12 months past · 3 months futureILMN activity timeline
Executive Branch ConflictsILMN held by Trump-administration officials
Lifetime Government AwardsILMN federal contracts by year
Politicians Trading ILMNMembers of Congress with recent ILMN positions
Congressional TradesWho in Congress is trading ILMN
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting ILMNLive legislation impacting this stock
Political ProfileWhere ILMN sits in Washington
[object Object]
STRUCTURAL: High government dependence via $139.5M in federal contracts across 11 agencies (`get_government_precedent`) and executive branch exposure via a Trump-held stock position (`get_executive_branch_exposure`). EVIDENTIARY: Mixed congressional trading activity with 4 distinct purchase events and 6 distinct sale events in the last 12 months (`Top congressional traders`). Zero corporate insider buys in 180 days (`get_corporate_insider_signal`). Net: Strong structural ties offset by neutral-to-weak evidentiary signals from traders and insiders.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Regulatory scrutiny of payments to healthcare professionalsDepartment of Health and Human Services"`get_political_influence.doctor_payments` shows $3.96M in payments to 106 doctors in 2024."
Regulatory opportunities
-
Continued federal procurement for genomic research and public healthDepartment of Health and Human Services"`get_government_precedent.federal_contracts_summary` shows $139.5M in total obligations, with HHS as a primary agency."
Capitol Hill AlliesChampions & critics
Live signals + predictions for ILMN — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades ILMN
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord